Bispecific antibodies rise again

Name: Bispecific antibodies rise again
Creator: Ken, Garber
Keywords: 0301 basic medicine, 0303 health sciences, 03 medical and health sciences, United States Food and Drug Administration, Antibodies, Bispecific, Humans, Precursor Cell Lymphoblastic Leukemia-Lymphoma, United States, 3. Good health

Ken, Garber

Found an issue? Give us feedback

Nature Reviews Drug ...arrow_drop_down

Nature Reviews Drug Discovery

Article . 2014 . Peer-reviewed

License: Springer TDM

Data sources: Crossref

Nature Reviews Drug Discovery

Article . 2015

Data sources: Europe PubMed Central

https://dx.doi.org/10.1038/nrd...

Article

Data sources: Microsoft Academic Graph

Bispecific antibodies rise again

descriptionPublicationkeyboard_double_arrow_right Article 31 Oct 2014 English Publisher:Springer Science and Business Media LLCJournal:Nature Reviews Drug Discovery, volume 13, pages 799-801 (issn: 1474-1776, eissn: 1474-1784,

Copyright policy )

Authors: Ken, Garber;

doi: 10.1038/nrd4478

pmid: 25359367

Bispecific antibodies rise again

- Summary
- Subjects
- Metrics

Abstract

Amgen's blinatumomab is setting the stage for a bispecific revival, enabled by new formats that may solve the field's long-standing problems.

Keywords

United States Food and Drug Administration, Antibodies, Bispecific, Humans, Precursor Cell Lymphoblastic Leukemia-Lymphoma, United States

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	111
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 1%